Navigation Links
BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
Date:12/4/2008

lity and length of stay and avoiding the increased costs associated with treating complications.

"CareFocus has been a tremendous asset to our organization and is a great example of how information technology is improving our delivery of care," said David House, vice president and chief information officer at BAPTIST HEALTH. "This solution places the powerful clinical information we have in our system into a single, easy-to-use format and allows our clinicians to be more responsive to patient needs. The idea was to identify at-risk patients faster, allowing our clinicians to intervene earlier, lower costs and improve outcomes. CareFocus enables us to do that."

BAPTIST HEALTH uses 100 CareFocus profiles across the system, broken out into 273 rounding lists. The pharmacy uses 37 of these profiles and has integrated them with Micromedex Healthcare Solutions drug reference information, another Thomson Reuters' offering, for a complete quality improvement solution.

Due to the initial success in the pharmacy, BAPTIST HEALTH has deployed the remaining profiles across several departments including infection control, case coordination, stroke center, nutrition and food services, nursing, and respiratory care.

"With CareFocus, our pharmacists are more efficient and have a more significant impact on patient care," said Tonya Robertson, Pharm.D., BCPS, pharmacy clinical coordinator for BAPTIST HEALTH Medical Center-Little Rock. "For example, we are using it to improve hospital vaccination rates, identify patients needing renal dose adjustments, and find opportunities to provide more cost-effective medications."

"CareFocus adds an extra safety net to guard our patients against adverse events from medications," adds Becky Layes, Pharm.D., pharmacist coordinator at BAPTIST HEALTH Rehabilitation Institute. "It places the information of our patients -- who might be at increased risk of havi
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sentillion and Baptist Health System to Speak at Upcoming Gartner Identity & Access Management Summit
2. Baptist Health System Deploys Sentillions Vergence Solution to Provide Secure Identity and Access Management to 3,000 Clinicians
3. Leading Neurologist Opens Missouri Baptist Medical Centers First MS Center
4. Alabamas Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns
5. BlueCross Recognizes Baptist Womens Hospital
6. Metrologic and Wake Forest University Baptist Medical Center Sponsored Healthcare Educational Forum
7. Valley Baptist Health System Leveraging TITAN Technology Partners Hosting and Managed Services
8. Baptist Memorial Health Care Donates More Than $3 Million to Tennessee Universities and Colleges
9. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
10. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
11. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., VIENNA, Va., Jan. 8 The Nationa...Inc., today announced the results of its organizat...on, President and CEO of Prematics, Inc., was elec...009 Board of Directors. The Collaborative builds ...rmation Community (AHIC), a federal advisory commi...
(Date:1/8/2009)..., , , Kelly Ripa Will Be Celebrity Host of S...Newswire/ -- Stand Up for a Cure today announced...ne,s Day show with Barry Manilow , in partnership... , The show will be held on February 14th, 2009 a...event go on sale Monday November 10th through Tick...
(Date:1/8/2009)..., WASHINGTON, Jan. 8 T...ability to plan and prepare for expensive long-ter...g to a new survey released today by America,s Heal...by StrategyOne on behalf of AHIP, found that 60 pe...ability to plan for future long-term care costs. ...
(Date:1/8/2009)...esearchers find it prolongs lives of key vision ce...Day News) -- Researchers working with mice have id...es of retinal cells in both healthy and diseased e...tments that would prevent blindness among people g... the scientists said. , The protein, known as h...
Breaking Medicine News(10 mins):Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3
...ikerwal, said today that the Government could save...get if it allowed GPs to refer patients directly f... of the proposal are contained in the AMA's Federa..., which was released yesterday. Dr Haikerwal sai...
...e banned from adding trans fatty acids to any food...aikerwal, said today. // 'The AMA believes the add...d out completely,' Dr Haikerwal said. 'In the mea...at have had trans fatty acids added to them should...
...men strongly about the side effects associated wit...er off //the development of severe blood clots in...ethinyl estradiol is available in the U.S with mor... in Canada. Use of this birth control patch has be...
...chool of Medicine have reported that genetics has ...rity (ROP) in preemies//, a disease known to hampe...nd could cause blindness. This report is published...“This is the first definitive study to show that g...
Other Medicine News:Health News:Genetics Plays A Crucial Role In Preemies' Destructive Eye Disease 2
(Date:1/8/2009)...rk,s second indication with clinical-stage, system..., FREMONT, Calif., Jan. 8 Quark Ph...tical company discovering and developing novel RNA...ounced that it has initiated patient dosing in its...ally administered siRNA drug candidate QPI-1002 (p...
(Date:1/8/2009)...Validate Novel Gene Expression Biomarkers Involved...Platform , , FREMONT, Calif., Jan. 8 /PRNewswir...letin Board: WGBS), a leading developer of state-o...y and stem cell research systems, today announced ...University of Texas Southwestern Medical Center f...
(Date:1/8/2009)... -- If you are taking prescription medicine,and f...the people taking,prescription medicine don,t tak...y forget, are busy with other priorities, or make ...en called the Achilles heel of modern,healthcare.... "Drugs don,t,work in people who don,t take them....
(Date:1/8/2009)...hio, Jan. 8 IntelligentMDx a develo...ssays, today announced that verification studies o...re complete. , , Under the verification protoc...and reproducibility and robustness of the BK Viral...in agreed with internally generated analytical per...
Breaking Medicine Technology:Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 1Actress Continues Fight Against Hospital Errors 26 Rise in MRSA Cases 17204 2Solar flares set the Sun quaking 2957 1Solar flares set the Sun quaking 2957 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 1HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 2HeartWare Announces Move to an Expanded Upgraded Manufacturing Facility 17200 3Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 1Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 4703 3
...and BASEL, Switzerland, June 27 /CNW/ -,Aspreva Ph... and,Roche today released preliminary results for ...olate mofetil, MMF) to intravenous,cyclophosphamid...r,inducing treatment response in the induction pha...though response rates were similar in both arms, t...
...IRE)--Jun 27, 2007 - Gentium S.p.A. (Nasdaq:,GENT)...reclinical,data that support the safety, activity,...brotide in combination with anticancer,therapy in ...update,from the Company,s ongoing Phase I/II clini... multiple myeloma with Defibrotide in,combination ...
Other Medicine Technology:Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 2Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 3Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 4Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 5Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 6Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 7Aspreva and Roche Announce Preliminary Results for Phase III Study,Evaluating CellCept in Lupus Nephritis 8Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
The MICROsed-System is the ideal system back up support to be used as front-line instrument with small workloads.
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy.
...g device for finger and alternate site testing fro... Comfort Zone Technology and Force Adjustment that... Comfort Zone Technology increases comfort when la... pain. This approach masks the pain of lancing to ...
Reduce the pain and hassle of testing. Unlike conventional lancing systems, the ACCU-CHEK Multiclix lancet device is the only one with a six-lancet drum. It offers the least painful testing, with les
Medicine Products: